The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Biden transition and vaccine hopes drive up stocks, oil and bitcoin

Tue, 24th Nov 2020 12:35

* Risk currencies gain as uncertainty retreats

* Vaccine could be released by mid-December

* Trump, government officials nod to formal Biden transition

* Bitcoin hits 19,000

* For a Reuters live blog on U.S., UK and European stock
markets,
click LIVE/ or type LIVE/ in a news window.

By Lawrence White and Julie Zhu

LONDON/HONG KONG, Nov 24 (Reuters) - Stocks, oil and risk
currencies, including bitcoin, gained on Tuesday as U.S.
President-elect Joe Biden got the formal go-ahead to begin his
transition to the White House.

The world's most popular cryptocurrency rose 3%
to near its record high, leading a surge in risk appetite as the
European STOXX 600 index climbed 0.6% and Brent
crude rose to its highest level since March at $46.52 a
barrel. Safe-haven assets such as gold fell.

After weeks of legal challenges to the election results,
U.S. General Services Administration chief Emily Murphy wrote to
Biden on Monday informing him the formal handover process could
begin.

President Donald Trump tweeted that he had told his team "do
what needs to be done with regard to initial protocols", an
indication he was moving towards a transition.

"Markets have been constrained by very high levels of
uncertainty on the U.S. political front and around vaccines for
weeks, so with those two going away investors are considering
the prospect of a return to normality in 2021," said Emmanuel
Cau, head of European equity strategy at Barclays.

Reports that Biden plans to nominate former Federal Reserve
Chair Janet Yellen to become the next Treasury Secretary further
boosted U.S. stocks on expectations she would pursue more
conventional policies than the departing Steven Mnuchin.

Futures for the S&P 500 rose 0.8% in European
trading hours, putting the 49-country MSCI world stocks index on
course to set a record high later.

Later on Tuesday, Biden and Vice President-elect Kamala
Harris are expected to formally introduce their appointments to
critical national security and foreign policy positions in
Wilmington, Delaware.

Japan's Nikkei jumped 2.5% to its highest level
since May 1991 overnight, with energy, real estate and financial
shares leading the advance.

Asia-Pacific shares outside Japan had ticked
up 0.4%. Australia's S&P/ASX 200 was 1.26% stronger,
touching its highest level in almost nine months, with energy
stocks leading the pack there.

Chinese blue chips were an outlier among positive
Asian shares, edging down 0.6%, as investors booked profits
following recent strong gains.

RISK ON

AstraZeneca and Oxford University said on Monday
that their COVID-19 vaccine, which is cheaper to make, easier to
distribute and faster to scale up than its rivals, could be as
much as 90% effective.

The progress made on COVID-19 vaccines helped drive risk
appetite, as investors looked past short-term economic pain from
the pandemic to a brighter 2021.

The South African rand and the Russian rouble
extended this week's winning run. MSCI's index of emerging
markets equities held the 32-month high reached in the
previous session.

The New Zealand dollar was also among the currency
gainers, rising as much as 0.9% to a two-year high of $0.6986 as
its central bank said house prices, which have been climbing
higher this year, could be included in its inflation basket.

The euro was gaining towards $1.19 again and the
dollar index, which tracks the dollar against a basket of
six major currencies, nudged down to 92.242.

Bitcoin broke past $19,000 for the first time in
nearly three years, as demand for assets perceived as resistant
to inflation grows.

Also spurred on by the vaccine hopes, oil reached levels not
seen since before the coronavirus pandemic began to spread in
March.

Brent crude futures rose 39 cents, or 0.9%, to
$46.45 a barrel to add to a more than 20% surge this month. U.S.
West Texas Intermediate crude added 46 cents, or 1.1%, to
$43.52.

"Progress on developing and distributing a vaccine de-risks
the path back to normal for oil markets," said Stephen Innes,
chief global markets strategist at financial services firm Axi.

SHORT-TERM PAIN

Amid the gains on Tuesday, however, were some reminders of
how the COVID-19 pandemic is inflicting economic pain. Germany's
gross domestic product grew by a record 8.5% in the third
quarter, but the Ifo institute's survey of business morale
pointed to fears of a recession to come as the index fell to
90.7 from a downwardly revised 92.5 in October.

The Turkish lira fell almost 1.5% to trade at 7.9899
per dollar, its weakest since Nov. 11, as new coronavirus
restrictions began and investors look for signs of sustained
central bank support.

In the bond markets, the yield on the U.S. benchmark 10-year
notes rose slightly to 0.87% as did those on most
European government bonds. Germany's 10-year yield was up 1
basis point to -0.58% in morning trade.

Gold fell 1% to $1,814 an ounce, having dropped 10%
this month.

(Reporting by Lawrence White, Julie Zhu and Katanga Johnson;
editing by Shri Navaratnam, Philippa Fletcher, Nick Macfie,
Larry King
For Reuters Live Markets blog on European and UK stock markets,
please click on:)

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.